tyrosine has been researched along with ristocetin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houghten, RA; Ruggeri, ZM; Vicente, V | 1 |
| Dong, JF; Hyun, W; López, JA | 1 |
| Fujimura, Y; Kume, S; Miura, S; Ozaki, Y; Satoh, K; Yatomi, Y | 1 |
| Feinstein, MB; Pumiglia, KM | 1 |
| Chen, JC; Ishimaru, S; Powell, LL; Serna, DL; Wang, D; Wilson, SE; Yomo, T | 1 |
| Dong , J; Gao, S; López, JA; McIntire, LV; Romo, GM; Schade, AJ; Turner, NT; Ye, P | 1 |
| Dong, Z; Jorieux, S; Kojima, T; Matsushita, T; Mazurier, C; Meyer, D; Nakayama, T; Sadler, JE; Saito, H | 1 |
| Chong, BH; Dawes, IW; Dong, JF; López, JA; Tait, AS | 1 |
| Andrews, RK; Auger, JM; Rhee, SG; Sekiya, F; Siraganian, RP; Suzuki-Inoue, K; Watson, SP; Wilde, JI | 1 |
| De Cristofaro, R; Di Stasio, E; Lavoretano, S; Lombardi, R; Mannucci, PM; Merati, G; Palla, R; Peyvandi, F; Romitelli, F | 1 |
| Feuring, M; Ganschow, A; Harenberg, J; Losel, R; Peiter, A; Ruf, A; Schultz, A; Wehling, M | 1 |
| Bäumler, W; Gartner, TK; Guerrero, JA; Jarvis, GE; Kanaji, T; Liu, J; Russell, S; Shafirstein, G; Varughese, KI; Ware, J | 1 |
| De Cristofaro, R; De Filippis, V; Lancellotti, S; Mannucci, PM; Palla, R; Peyvandi, F; Pitocco, D; Pozzi, N; Rocca, B; Rutella, S | 1 |
| Dai, K; Li, S; Liu, G; Shi, Q; Wang, Y; Wang, Z; Zhang, W | 1 |
| Handa, M; Ikeda, Y; Okamura, Y; Watanabe, N; Yoshida, H | 1 |
15 other study(ies) available for tyrosine and ristocetin
| Article | Year |
|---|---|
Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
Topics: Amino Acid Sequence; Asialoglycoproteins; Binding Sites; Blood Platelets; Crotalid Venoms; Disulfides; Humans; Molecular Sequence Data; Peptide Fragments; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Ristocetin; Serine; Tyrosine; von Willebrand Factor | 1990 |
Aggregation of mammalian cells expressing the platelet glycoprotein (GP) Ib-IX complex and the requirement for tyrosine sulfation of GP Ib alpha.
Topics: Animals; Biological Transport, Active; Calcium; Cell Aggregation; CHO Cells; Cricetinae; Humans; In Vitro Techniques; L Cells; Mice; Platelet Glycoprotein GPIb-IX Complex; Ristocetin; Sulfates; Temperature; Tyrosine; von Willebrand Factor | 1995 |
Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor.
Topics: Alkaloids; Blood Platelets; Calcium; Crotalid Venoms; Epoprostenol; Humans; Phosphoproteins; Phosphorylation; Phosphotyrosine; Platelet Aggregation; Platelet Membrane Glycoproteins; Ristocetin; Staurosporine; Tyrosine; von Willebrand Factor | 1995 |
Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is depe
Topics: Amino Acid Sequence; Biological Transport; Blood Platelets; Cytoskeleton; Enzyme Induction; Humans; Integrins; Molecular Sequence Data; Peptide Fragments; Phosphorylation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Receptors, Cell Surface; Receptors, Thrombin; Ristocetin; Thrombin; Tyrosine; von Willebrand Factor | 1993 |
Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Analysis of Variance; Anti-Bacterial Agents; Blood Platelets; Cell Degranulation; Collagen; Heart-Assist Devices; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Ristocetin; Thromboxane A2; Tirofiban; Tyrosine | 2000 |
Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
Topics: Amino Acid Sequence; Amino Acid Substitution; Binding Sites; Cell Adhesion; Cell Line; Crotalid Venoms; Glutamic Acid; Hemagglutinins; Humans; Kinetics; Ligands; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Platelet Glycoprotein GPIb-IX Complex; Protein Structure, Secondary; Recombinant Proteins; Ristocetin; Stress, Mechanical; Transfection; Tyrosine; von Willebrand Factor | 2001 |
Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond.
Topics: Anti-Bacterial Agents; Binding Sites; Biotinylation; Blood Platelets; Cell Line; Crotalid Venoms; Cysteine; Dimerization; Disulfides; Dose-Response Relationship, Drug; Epitope Mapping; Gene Deletion; Humans; Immunoglobulin G; Models, Molecular; Plasmids; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins; Ristocetin; Tyrosine; von Willebrand Factor | 2002 |
Site-directed mutagenesis of platelet glycoprotein Ib alpha demonstrating residues involved in the sulfation of tyrosines 276, 278, and 279.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; CHO Cells; Cricetinae; Crotalid Venoms; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Protein Processing, Post-Translational; Ristocetin; Sulfates; Transfection; Tyrosine; von Willebrand Factor | 2002 |
Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Chlorocebus aethiops; COS Cells; Enzyme Precursors; Intracellular Signaling Peptides and Proteins; Mice; Phospholipase C gamma; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Ristocetin; Syk Kinase; Type C Phospholipases; Tyrosine; von Willebrand Factor | 2004 |
Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13.
Topics: ADAM Proteins; ADAMTS13 Protein; Anti-Bacterial Agents; Cell Line; Cell Membrane; Chlorides; Electrophoresis, Polyacrylamide Gel; Humans; Hydrogen-Ion Concentration; Hydrolysis; Ions; Kinetics; Metalloendopeptidases; Protein Binding; Protein Conformation; Recombinant Proteins; Ristocetin; Salts; Sodium Chloride; Spectrometry, Fluorescence; Spectrophotometry; Time Factors; Transfection; Tyrosine; Ultraviolet Rays; Urea; von Willebrand Factor | 2005 |
Impact of ABO blood groups on tirofiban mediated inhibition of platelet function.
Topics: ABO Blood-Group System; Adult; Anti-Bacterial Agents; Blood Platelets; Factor VIII; Humans; Male; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Ristocetin; Tirofiban; Tyrosine; von Willebrand Factor | 2005 |
In vivo relevance for platelet glycoprotein Ibalpha residue Tyr276 in thrombus formation.
Topics: Amino Acid Substitution; Animals; Bleeding Time; Blood Coagulation; Carotid Artery Thrombosis; Chlorides; Collagen Type I; Ferric Compounds; Humans; Lasers; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation, Missense; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Point Mutation; Ristocetin; Thrombin; Tyrosine; von Willebrand Factor | 2008 |
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Binding Sites; Blood Platelets; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydrolysis; Male; Methionine; Middle Aged; Oxidative Stress; Peptide Fragments; Peroxynitrous Acid; Platelet Aggregation; Protein Multimerization; Ristocetin; Tyrosine; von Willebrand Diseases; von Willebrand Factor | 2010 |
Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcium; Chelating Agents; Contractile Proteins; Egtazic Acid; Filamins; Hemostasis; Humans; Hypergravity; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Ristocetin; Thrombosis; Time Factors; Tirofiban; Tyrosine; Weightlessness Simulation | 2010 |
Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation.
Topics: Aspirin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gs; Hemostasis; Humans; Ligands; Platelet Aggregation; Quinolines; Ristocetin; Shear Strength; Tirofiban; Tyrosine; Urea; von Willebrand Factor | 2011 |